Manufacturer profileBIOSYSTEMS S.A.
IndonesiaSpain20 products registered
VerifiedKemenkes (Ministry of Health) · official registry
20
Total Products
20
Product Names
1
Product Classes
2
Risk Classes
Regulatory footprint
Search BIOSYSTEMS S.A. across other regulatory registries
Thailand
European Union
Colombia
South Korea
Canada
EcuadorRisk classification breakdown
Distribution of products across risk classes
Kelas Resiko : B1575.0% of total
Kelas Resiko : C525.0% of total
Product class portfolio
Products organized by product class
Kelas : 2
BIOSYSTEMS RHEUMATOID FACTORS (RF) STANDARD, BIOSYSTEMS CARBON DIOXIDE (CO2), BIOSYSTEMS APOLIPOPROTEIN B (APO B), BIOSYSTEMS SEROLOGY NEGATIVE CONTROL, BIOSYSTEMS Homocysteine Standards ... and 15 more products in this class
20 Products
Recent registrations (20 most recent)
Most recently registered products with Ministry of Health
BIOSYSTEMS RHEUMATOID FACTORS (RF) STANDARD
Jul 15, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : C
BIOSYSTEMS CARBON DIOXIDE (CO2)
Jun 11, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : B
BIOSYSTEMS APOLIPOPROTEIN B (APO B)
Jun 11, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : B
BIOSYSTEMS SEROLOGY NEGATIVE CONTROL
Jun 10, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : B
BIOSYSTEMS Homocysteine Standards
Jun 10, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : B
BIOSYSTEMS HOMOCYSTEINE CONTROL I
Apr 3, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : B
BIOSYSTEMS HOMOCYSTEINE CONTROL II
Apr 3, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : B
BIOSYSTEMS FIBRINOGEN CONTROL PLASMA
Apr 3, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : B
BIOSYSTEMS APOLIPOPROTEIN B (APO B) STANDARD
Apr 3, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : B
BIOSYSTEMS CK-MB CONTROL SERUM II
Apr 3, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : B
BIOSYSTEMS Copper-Paesa
Apr 2, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : B
BIOSYSTEMS Rheumatoid Factors (RF) - Slide
Apr 1, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : C
BIOSYSTEMS Anti-Streptolysin O (ASO)-Slide
Apr 1, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : C
BIOSYSTEMS Fibrinogen Clauss
Apr 1, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : C
BIOSYSTEMS beta2-Microglobulin Control Urine
Apr 1, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : B
BIOSYSTEMS Activated Partial Thromboplastin Time (APTT)
Apr 1, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : C
BIOSYSTEMS C-Reactive Protein (CRP) - SLIDE
Apr 1, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : B
BIOSYSTEMS Cholesterol HDL Direct
Mar 31, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : B
BIOSYSTEMS FECAL OCCULT BLOOD (FOB) CONTROLS
Mar 26, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : B
BIOSYSTEMS CK-MB Control Serum
Mar 25, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : B
About this profile
BIOSYSTEMS S.A. from Spain is a medical device manufacturer with 20 registered products in the Indonesia Ministry of Health database through Pure Global AI's free platform. The company produces 20 unique product types across 1 product class.
This page provides comprehensive manufacturer intelligence including complete product portfolio, risk class distribution, and product class analysis. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify manufacturers, analyze portfolios, and discover partnership opportunities efficiently.